119 related articles for article (PubMed ID: 12113806)
21. Synthesis of new cardioselective M2 muscarinic receptor antagonists.
Mandelli GR; Maiorana S; Terni P; Lamperti G; Colibretti ML; Imbimbo BP
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1611-22. PubMed ID: 11086886
[TBL] [Abstract][Full Text] [Related]
22. M(2)/M(4)-muscarinic receptors mediate automodulation of acetylcholine outflow from mouse cortex.
Iannazzo L; Majewski H
Neurosci Lett; 2000 Jun; 287(2):129-32. PubMed ID: 10854729
[TBL] [Abstract][Full Text] [Related]
23. Muscarinic receptors in rat uterus.
Pennefather JN; Gillman TA; Mitchelson F
Eur J Pharmacol; 1994 Sep; 262(3):297-300. PubMed ID: 7813596
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of some Galbulimima alkaloids related to himbacine.
Darroch SA; Taylor WC; Choo LK; Mitchelson F
Eur J Pharmacol; 1990 Jun; 182(1):131-6. PubMed ID: 2401311
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
26. The cardio-selectivity of himbacine: a muscarine receptor antagonist.
Anwar-ul S; Gilani H; Cobbin LB
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):16-20. PubMed ID: 3951563
[TBL] [Abstract][Full Text] [Related]
27. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
Mitsuya M; Kobayashi K; Kawakami K; Satoh A; Ogino Y; Kakikawa T; Ohtake N; Kimura T; Hirose H; Sato A; Numazawa T; Hasegawa T; Noguchi K; Mase T
J Med Chem; 2000 Dec; 43(26):5017-29. PubMed ID: 11150173
[TBL] [Abstract][Full Text] [Related]
28. The allosteric binding profile of himbacine: a comparison with other cardioselective muscarinic antagonists.
Lee NH; el-Fakahany EE
Eur J Pharmacol; 1990 Apr; 179(1-2):225-9. PubMed ID: 2364985
[TBL] [Abstract][Full Text] [Related]
29. Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring.
Xia Y; Chackalamannil S; Clasby M; Doller D; Eagen K; Greenlee WJ; Tsai H; Agans-Fantuzzi J; Ahn HS; Boykow GC; Hsieh Y; Lunn CA; Chintala M
Bioorg Med Chem Lett; 2007 Aug; 17(16):4509-13. PubMed ID: 17574850
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of Diphenidol: novel M4 muscarinic receptor antagonists.
Varoli L; Angeli P; Buccioni M; Burnelli S; Fazio N; Marucci G; Recanatini M; Spampinato S
Med Chem; 2008 Mar; 4(2):121-8. PubMed ID: 18336331
[TBL] [Abstract][Full Text] [Related]
31. Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes.
Sagara Y; Sagara T; Mase T; Kimura T; Numazawa T; Fujikawa T; Noguchi K; Ohtake N
J Med Chem; 2002 Feb; 45(4):984-7. PubMed ID: 11831911
[TBL] [Abstract][Full Text] [Related]
32. Receptor classification using antagonists without determining pA2 values.
Kromer W
Trends Pharmacol Sci; 1991 Jan; 12(1):11-3. PubMed ID: 2006539
[TBL] [Abstract][Full Text] [Related]
33. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
Waelbroeck M; Tastenoy M; Camus J; Christophe J
Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
[TBL] [Abstract][Full Text] [Related]
34. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
[TBL] [Abstract][Full Text] [Related]
36. Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring.
Xia Y; Chackalamannil S; Chan TM; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Tsai H; Wang Y; Ahn HS; Boykow GC; McPhail AT
Bioorg Med Chem Lett; 2006 Sep; 16(18):4969-72. PubMed ID: 16824760
[TBL] [Abstract][Full Text] [Related]
37. Binding studies on two functional cardioselective antimuscarinic compounds.
Choo LK; Mitchelson F
J Pharm Pharmacol; 1988 Apr; 40(4):288-9. PubMed ID: 2900313
[TBL] [Abstract][Full Text] [Related]
38. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
Lin BQ; Ji H; Li P; Jiang Y; Fang W
Eur J Pharmacol; 2006 Dec; 551(1-3):125-30. PubMed ID: 17027747
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Hu Z; Clader JW; Greenlee W; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2247-50. PubMed ID: 11055330
[TBL] [Abstract][Full Text] [Related]
40. Sulfide analogues as potent and selective M(2) muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Hu Z; McKittrick BA; Greenlee W; Ruperto V; Duffy RA; Lachowicz JE
Bioorg Med Chem Lett; 2002 Apr; 12(7):1087-91. PubMed ID: 11909724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
